Enterprise Financial Services Corp Moderna, Inc. Transaction History

Enterprise Financial Services Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $34,394 - $75,092	-155 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $909 - $1,644	7 Added 4.73%	155 $36,000
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $17,359 - $29,570	-159 Reduced 51.79%	148 $20,000
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $12,687 - $32,782	-193 Reduced 38.6%	307 $32,000
Q3 2020 Nov 13, 2020	SELL	$54.34 - $94.85 $2,390 - $4,173	-44 Reduced 8.09%	500 $35,000
Q2 2020 Aug 04, 2020	BUY	$29.67 - $80.0 $15,398 - $41,520	519 Added 2076.0%	544 $35,000
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $444 - $789	25 New	25 $1,000

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.